http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010158869-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cc0567930d1066b38c8f9f044572203
publicationDate 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2010158869-A1
titleOfInvention Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
abstract The present invention provides devices, small interfering RNAs, and methods for treating a neurodegenerative disorder comprising the steps of surgically implanting a catheter so that a discharge portion of the catheter lies adjacent to a predetermined infusion site in a brain, and discharging through the discharge portion of the catheter a predetermined dosage of at least one substance capable of inhibiting production of at least one neurodegenerative protein. The present invention also provides valuable small interfering RNA vectors, systems, and methods for treating Huntington's disease in vivo without impairment of cell endoplasmic reticulum, spontaneous motor activity, or locomotor activity of a patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8651274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8646921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668344-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668343-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10507183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8661573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8662684-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11511035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8672490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3354644-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4212514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8641210-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9964649-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020212597-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780052-B2
priorityDate 2003-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6042579-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006257912-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24181110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128600132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127978224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID668

Total number of triples: 81.